Number of chemical drug applications requiring technical reviews in China 2018-2021
In 2021, the Chinese Center for Drug Evaluation of the National Medical Products Administration (NMPA) received almost 9,200 drug evaluation applications that were subjected to technical reviews. Around 6,800 of such applications were concerning chemical drug products, representing a growth of more than 25 percent from the previous year.